TR199801161T2 - 2,7-�kame edilmi� oktahidro-pirdo (1,2-A) pirazin t�revleri. - Google Patents

2,7-�kame edilmi� oktahidro-pirdo (1,2-A) pirazin t�revleri.

Info

Publication number
TR199801161T2
TR199801161T2 TR1998/01161T TR9801161T TR199801161T2 TR 199801161 T2 TR199801161 T2 TR 199801161T2 TR 1998/01161 T TR1998/01161 T TR 1998/01161T TR 9801161 T TR9801161 T TR 9801161T TR 199801161 T2 TR199801161 T2 TR 199801161T2
Authority
TR
Turkey
Prior art keywords
revleri
edilmi
amekame
oktahydro
pyrdo
Prior art date
Application number
TR1998/01161T
Other languages
English (en)
Turkish (tr)
Inventor
A.Sanner Mark
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR199801161T2 publication Critical patent/TR199801161T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TR1998/01161T 1995-12-21 1996-11-06 2,7-�kame edilmi� oktahidro-pirdo (1,2-A) pirazin t�revleri. TR199801161T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US898895P 1995-12-21 1995-12-21

Publications (1)

Publication Number Publication Date
TR199801161T2 true TR199801161T2 (xx) 1998-10-21

Family

ID=21734893

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01161T TR199801161T2 (xx) 1995-12-21 1996-11-06 2,7-�kame edilmi� oktahidro-pirdo (1,2-A) pirazin t�revleri.

Country Status (33)

Country Link
US (1) US5714487A (en:Method)
EP (1) EP0874849B1 (en:Method)
JP (1) JP3204456B2 (en:Method)
KR (1) KR100286786B1 (en:Method)
CN (1) CN1061350C (en:Method)
AR (1) AR005102A1 (en:Method)
AT (1) ATE205846T1 (en:Method)
AU (1) AU704578B2 (en:Method)
BR (1) BR9612246A (en:Method)
CA (1) CA2240594C (en:Method)
CO (1) CO4480107A1 (en:Method)
CZ (1) CZ192998A3 (en:Method)
DE (1) DE69615404T2 (en:Method)
DK (1) DK0874849T3 (en:Method)
ES (1) ES2161377T3 (en:Method)
GR (1) GR3037060T3 (en:Method)
GT (1) GT199600101A (en:Method)
HU (1) HUP9900611A3 (en:Method)
IL (1) IL124453A0 (en:Method)
MA (1) MA26413A1 (en:Method)
MX (1) MX9805088A (en:Method)
NO (1) NO309936B1 (en:Method)
NZ (1) NZ320537A (en:Method)
PE (1) PE25998A1 (en:Method)
PL (1) PL327539A1 (en:Method)
PT (1) PT874849E (en:Method)
RU (1) RU2162470C2 (en:Method)
SI (1) SI0874849T1 (en:Method)
TN (1) TNSN96164A1 (en:Method)
TR (1) TR199801161T2 (en:Method)
TW (1) TW479058B (en:Method)
WO (1) WO1997023482A1 (en:Method)
ZA (1) ZA9610781B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0982030A3 (en) 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
AU767089B2 (en) * 1999-02-05 2003-10-30 Pharmacia & Upjohn Company Process to prepare (5R)-(methylamino)-5,6-dihydro-4H- imidazo(4,5,1-ij)-quinolin-2(1H)-one
DE60011858T2 (de) 1999-09-10 2005-08-25 Mitsubishi Jidosha Kogyo K.K. Stufenloses Getriebe
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
MXPA02002694A (es) * 1999-09-14 2002-07-30 Aventis Pharm Prod Inc Derivados de benzisoxazolil-, piridoisoxazolil-y benzotienil-fenoxi utiles como antagonistas de d4.
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
AU2002331229B2 (en) * 2001-09-19 2008-05-15 Merck Patent Gmbh Novel use of substituted aminomethyl chromans
TW200801005A (en) * 2005-08-15 2008-01-01 Astrazeneca Ab Acetylenic piperazines as metabotropic glutamate receptor antagonists
US7728031B2 (en) * 2006-02-24 2010-06-01 Abbott Laboratories Octahydro-pyrrolo[3,4-b]pyrrole derivatives
WO2013049164A1 (en) * 2011-09-29 2013-04-04 Abbvie Inc. SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS
AU2019336671B2 (en) * 2018-09-04 2025-06-05 Contineum Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists
US11752149B2 (en) 2019-12-02 2023-09-12 Pipeline Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US5122515A (en) * 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
JP3058945B2 (ja) * 1990-10-26 2000-07-04 三共株式会社 N−(3,3−ジ置換アクリロイル)ピペラジン誘導体
CA2146018A1 (en) * 1992-10-23 1994-05-11 Paul David Leeson Dopamine receptor subtype ligands
ES2133416T3 (es) * 1992-10-23 1999-09-16 Merck Sharp & Dohme Ligandos de subtipos de receptores de dopamina.
WO1996004250A1 (en) * 1994-08-05 1996-02-15 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
EP0783503B1 (en) * 1994-09-30 2001-11-28 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
US5576314A (en) * 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity

Also Published As

Publication number Publication date
PT874849E (pt) 2002-01-30
TW479058B (en) 2002-03-11
TNSN96164A1 (fr) 2005-03-15
US5714487A (en) 1998-02-03
ES2161377T3 (es) 2001-12-01
GT199600101A (es) 1998-06-12
DE69615404T2 (de) 2002-06-06
CN1205704A (zh) 1999-01-20
CO4480107A1 (es) 1997-07-09
CZ192998A3 (cs) 1999-05-12
EP0874849B1 (en) 2001-09-19
DK0874849T3 (da) 2001-11-19
AU7328096A (en) 1997-07-17
NO309936B1 (no) 2001-04-23
CN1061350C (zh) 2001-01-31
IL124453A0 (en) 1998-12-06
NO982843D0 (no) 1998-06-19
ZA9610781B (en) 1998-06-22
SI0874849T1 (en:Method) 2001-12-31
EP0874849A1 (en) 1998-11-04
BR9612246A (pt) 1999-07-13
NZ320537A (en) 1999-03-29
PL327539A1 (en) 1998-12-21
MA26413A1 (fr) 2004-12-20
NO982843L (no) 1998-06-19
KR100286786B1 (ko) 2001-04-16
WO1997023482A1 (en) 1997-07-03
DE69615404D1 (de) 2001-10-25
HUP9900611A3 (en) 2000-09-28
CA2240594A1 (en) 1997-07-03
CA2240594C (en) 2001-07-24
RU2162470C2 (ru) 2001-01-27
MX9805088A (es) 1998-10-31
KR19990076616A (ko) 1999-10-15
ATE205846T1 (de) 2001-10-15
JP3204456B2 (ja) 2001-09-04
PE25998A1 (es) 1998-05-19
AR005102A1 (es) 1999-04-14
HUP9900611A2 (hu) 1999-08-30
JPH11508920A (ja) 1999-08-03
AU704578B2 (en) 1999-04-29
GR3037060T3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
TR199801161T2 (xx) 2,7-�kame edilmi� oktahidro-pirdo (1,2-A) pirazin t�revleri.
DK0639186T3 (da) Taxolderivater
KR950702829A (ko) 신경계 퇴행성 질환의 치료에 유용한 아나바세인 유도체
TR199701567T1 (xx) Rapamisin t�revleri.
HUP0301777A2 (hu) Tiroidreceptor-ligandum anilin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
TR200100694T2 (tr) Opioid alıcı aktivitesine sahip 4,4-Biarilpiperidin türevleri
DE69730415D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
GB9507799D0 (en) Metalloproteinase inhibitors
TR199902291T2 (xx) �kame edilmi� 4-Arilmetilen-2-imino-2, 3-dihidrotiazoller
FI841181A0 (fi) Nya n-fenyl-n'- cykloalkylalkanoylpiperaziner och foerfarande foer deras framstaellning.
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
NO953957D0 (no) Tetracykliske forbindelser som dopaninagonister
ATE173256T1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
ATE88468T1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE69328366D1 (de) Benzopyran und benzoxazin-derivate
CA2103590A1 (en) Benzamide derivative
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
ATE187720T1 (de) Diosmetin derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE356814T1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
DE69729083D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
EP1241165A4 (en) OPTICALLY ACTIVE CHROMAN AND THIOCHROME DERIVATIVES
KR900001367A (ko) 폐의 폐색성 기능장애 및/또는 출뇨관 기능장애 치료용 약제로서 치환된 3,4-디하이드로-2h-벤조피란의 용도
DE69725133D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central